PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,655 | -1.9% | 16,882 | 0.0% | 0.00% | – |
| Q2 2023 | $105,681 | +50.5% | 16,882 | +14.6% | 0.00% | – |
| Q1 2023 | $70,238 | -45.2% | 14,725 | 0.0% | 0.00% | – |
| Q4 2022 | $128,108 | -26.9% | 14,725 | 0.0% | 0.00% | – |
| Q3 2022 | $175,228 | -10.6% | 14,725 | +7.2% | 0.00% | – |
| Q2 2022 | $196,000 | -8.8% | 13,741 | +33.3% | 0.00% | – |
| Q1 2022 | $215,000 | -9.7% | 10,309 | 0.0% | 0.00% | – |
| Q4 2021 | $238,000 | -22.2% | 10,309 | +0.3% | 0.00% | -100.0% |
| Q3 2021 | $306,000 | -12.8% | 10,278 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $351,000 | +69.6% | 10,278 | +63.3% | 0.00% | – |
| Q1 2021 | $207,000 | -32.1% | 6,295 | +26.8% | 0.00% | -100.0% |
| Q4 2020 | $305,000 | – | 4,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |